News October 16, 2015 JHU FastForward names new leaders – Technical.ly Baltimore Brian Stansky is the new director of Johns Hopkins’ incubator program for startups, according to… Super User 0 Love0
News October 16, 2015 REDI Commercial Broker Breakfast 2015 Join REDI on October 22nd from 8:00-10:00am for the second edition of the Commercial Broker… Super User 0 Love0
News October 16, 2015 MedImmune joins GSK, Vanderbilt U in Human Vaccines Project – FierceVaccines AstraZeneca's ($AZN) MedImmune is joining the likes of Vanderbilt University and GlaxoSmithKline ($GSK) as a… Super User 0 Love0
News October 16, 2015 Here’s What Happens When You Drink Red Wine Every Night | TIME Resveratrol for the win: Red wine drinkers had better levels of HDL cholesterol, better sleep… Super User 0 Love0
News October 16, 2015 Roche (RHHBY) to Buy Adheron Therapeutics for $580M – NASDAQ.com Large pharmaceutical companies are often on the lookout for small strategic acquisitions of companies that… Super User 0 Love0
News October 15, 2015 23andMe raises $115M to grow its DNA health test technology globally – VentureBeat 23andMe has raised a substantial $115 million in a series E round led by Fidelity… Super User 0 Love0
News October 14, 2015 APLU Names Six Public Research Institutions as Finalists for 2015 Innovation & Economic Prosperity University Awards The Association of Public and Land-grant Universities (APLU) today named six public research institutions as… Super User 0 Love0
News October 14, 2015 J. Craig Venter Debuts Elite Testing Service Via Health Nucleus – Xconomy In a move that takes concierge medicine to a whole new level, human genome pioneer… Super User 0 Love0
News October 14, 2015 Human Vaccines Project Partners with MedImmune to Help Accelerate Research and Development… — NEW YORK, Oct. 13, 2015 /PRNewswire-USNewswire/ — MedImmune is the newest member of the Human Vaccines Project, which will help to accelerate… Super User 0 Love0
News October 14, 2015 Vaccine technology developed at Johns Hopkins could lead to treatment for peanut allergies A $300 million worldwide licensing agreement announced last week between Immunomic Therapeutics and Astellas Pharma… Super User 0 Love0